ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674066 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674066; 2) Community: the network communities that were significantly associated with the response to NSC 674066; 3) Molecule: the relationships between components within communities and NSC 674066; 4) MDR: the compounds that were significantly associated with the NSC 674066.

NSC Compound Enrichment Correlation
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.0244632509325736 0.29106972
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0244632509325736 0.45816784
NSC 618857 4-Piperidinone, 3,5-bis[[(4-methylthio)phenyl]methylene]-, hydrochloride 0.0244718705444135 -0.19429387
NSC 625985 Null 0.0244718705444135 0.53266848
NSC 632877 Dicarbonyl[1-(phenylazo)naphthaline-2-olato(O1,N1)]- iridium(I) 0.0244718705444135 0.49991113
NSC 636859 Cuspidatin C 0.0244718705444135 0.45431056
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.0244718705444135 0.460806
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0244718705444135 0.4594119
NSC 680553 2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester 0.0244718705444135 -0.50465557
NSC 696864 Null 0.0244718705444135 0.65307927
Total:118  Current:73    [First] [Prev] [Next] [Last]